earliest
confirm
case
sever
acut
respiratori
syndrom
sar
occur
novemb
guangdong
provinc
china
toward
end
epidem
report
juli
recogn
case
countri
region
worldwid
implic
death
due
unpreced
intern
effort
sar
coronaviru
sarscov
identifi
causal
agent
late
march
first
complet
genom
sequenc
publish
april
one
month
later
sarslik
coronavirus
found
palm
civet
anim
guangdong
china
first
evid
possibl
interspeci
transmiss
viru
reemerg
isol
sar
case
asia
decemb
anhui
provinc
beij
china
late
april
confirm
widespread
conjectur
sarscov
like
human
year
come
reemerg
sar
case
make
legitim
critic
reevalu
time
origin
sarscov
put
code
region
cover
sarscov
genom
approxim
twothird
genom
side
encod
nonstructur
protein
onethird
side
encod
four
structur
protein
spike
glycoprotein
envelop
e
membran
nucleocapsid
n
spike
glycoprotein
especi
subdomain
respons
bind
specif
receptor
target
cell
rna
polymeras
gene
two
major
loci
estim
mutat
rate
rna
virus
retrovirus
critic
also
challeng
trace
rapidli
evolv
path
rate
estim
positivestrand
ssrna
viru
appear
similar
rang
eg
per
site
per
year
negativestrand
ssrna
viru
although
direct
comparison
possibl
mutat
rate
could
estim
differ
region
gene
estim
mutat
rate
coronaviru
sarscov
phylogenet
link
moder
high
compar
other
categori
ssrna
virus
exampl
estim
per
site
per
year
infecti
bronchiti
viru
previou
studi
howev
estim
mutat
rate
appear
wider
rang
retroviru
detail
present
discuss
section
sarscov
evolv
import
implic
strateg
plan
prevent
sar
epidem
develop
vaccin
antibodi
mutat
rate
among
fundament
aspect
sequenc
evolut
pathogen
evolv
slowli
better
chanc
develop
effect
long
last
vaccin
success
treatment
patient
particular
geograph
region
like
effect
patient
area
hand
pathogen
particularli
gene
code
major
antigen
evolv
rapidli
effect
strategi
prevent
transmiss
sarscov
must
topprior
effect
vaccin
program
may
problemat
purpos
studi
improv
understand
evolutionari
mechan
sarscov
genom
particular
address
issu
mutat
rate
time
emerg
sarscov
human
popul
report
estim
mutat
rate
sarscov
use
avail
complet
genom
sequenc
whose
clinic
histori
either
certain
could
infer
sourc
genom
sequenc
use
studi
method
estim
mutat
rate
present
method
section
diverg
time
infer
base
inform
summar
figur
tabl
show
mutat
rate
estim
three
strategi
first
strategi
use
adjust
sequenc
error
potenti
mutat
cell
cultur
mutat
rate
estim
nucleotid
substitut
per
site
per
year
use
sequenc
gener
mainland
china
nucleotid
substitut
per
site
per
year
use
urbani
sequenc
second
strategi
use
mutat
rate
estim
nucleotid
substitut
per
site
per
year
lower
use
first
strategi
expect
mutat
rate
estim
use
third
strategi
lowest
nucleotid
substitut
per
site
per
year
use
sequenc
gener
mainland
china
nucleotid
substitut
per
site
per
year
use
urbani
sequenc
sampl
proport
nonsynonym
substitut
per
nonsynonym
site
ka
proport
synonym
substitut
per
synonym
site
ks
lead
kak
ratio
nonstructur
region
structur
region
particular
valu
kak
tabl
show
rate
nucleotid
substitut
code
region
sequenc
overal
rate
nonsynonym
synonym
substitut
per
site
per
year
respect
nonsynonym
rate
higher
three
gene
e
n
suggest
mutat
might
increas
antigen
although
number
mutat
use
calcul
rate
small
mutat
rate
estim
earlier
allow
us
estim
age
recent
common
ancestor
mrca
sampl
recent
time
origin
sarscov
phylogeni
reconstruct
neighborjoin
method
midpoint
root
maximum
parsimoni
overal
consist
epidem
addit
file
sequenc
mainland
china
cluster
togeth
separ
remain
sequenc
includ
clinic
relat
index
patient
distantli
separ
sequenc
assum
mrca
root
phylogeni
age
mrca
diverg
time
sequenc
use
mutat
rate
estim
found
mrca
could
aliv
time
march
novemb
strategi
februari
octob
strategi
even
earlier
strategi
critic
implic
analys
entir
plausibl
mrca
sampl
could
aliv
earli
spring
uncertainti
qualiti
sequenc
data
incomplet
inform
patient
histori
two
limit
factor
studi
worldwid
race
understand
novel
viru
provid
unpreced
set
complet
genom
sequenc
pathogen
interv
week
like
sideeffect
race
might
elev
error
rate
releas
sequenc
gener
error
analysi
among
sequenc
variat
report
mani
gener
randomli
algorithm
align
multipl
sequenc
therefor
remov
adjust
concern
led
us
wait
sequenc
use
studi
significantli
revis
gener
manual
adjust
multiplesequ
align
still
error
unavoid
partli
due
intrins
error
rate
sequenc
technolog
exampl
among
common
variat
could
uniqu
assign
intern
branch
phylogeni
incongru
like
partial
due
sequenc
error
exist
sequenc
error
also
infer
examin
ratio
transit
versu
transversion
chang
nucleotid
substitut
occur
randomli
two
transversion
substitut
averag
transit
substitut
ratio
transit
transvers
howev
transit
gener
favor
transvers
mani
organ
exampl
ratio
approxim
human
genom
ratio
discuss
extens
rna
virus
howev
appear
higher
mammalian
genom
base
two
previou
report
influenza
viru
marburg
viru
studi
transit
substitut
transversion
substitut
observ
among
sequenc
thu
ratio
ratio
five
sequenc
mainland
china
consider
smaller
observ
eleven
sequenc
suggest
sequenc
mainland
china
may
erron
sequenc
hand
ratio
singleton
variat
much
lower
ratio
nonsingleton
variant
indic
singleton
problemat
unknown
level
error
sequenc
conserv
approach
estim
mutat
rate
taken
three
strategi
use
reduc
effect
sequenc
error
one
aggress
two
mutat
rate
estim
first
two
strategi
quit
similar
third
strategi
variant
uniqu
given
isol
exclud
strategi
conserv
amount
singleton
expect
larg
rapid
expand
environ
see
therefor
mutat
rate
place
rang
nucleotid
substitut
per
site
per
year
base
sequenc
use
rate
along
rate
synonym
substitut
estim
studi
close
recent
report
use
anoth
approach
comparison
coronavirus
rate
lower
mous
hepat
viru
similar
transmiss
gastroenter
viru
higher
infecti
bronchiti
viru
tabl
estim
mutat
rate
order
magnitud
rna
virus
exampl
nucleotid
substitut
per
site
per
year
influenza
virus
estim
mutat
rate
hiv
appear
wide
rang
like
mutat
rate
sarscov
higher
hiv
therefor
sarscov
unusu
coronaviru
rna
viru
term
speed
nucleotid
chang
one
challeng
task
therefor
find
variat
led
sarscov
uniqu
rna
virus
especi
coronavirus
variat
chang
function
help
transmit
human
nucleotid
variat
distribut
along
entir
genom
base
align
annot
genbank
open
read
frame
variat
includ
gene
encod
polymeras
spike
glycoprotein
envelop
membran
nucleocapsid
protein
estim
mutat
rate
suggest
approxim
new
mutat
occur
month
viru
assum
overal
uniform
mutat
rate
howev
rate
nonsynonym
substitut
might
vari
cours
sarscov
evolut
observ
excess
mutat
amino
acid
chang
extern
branch
phylogeni
larg
sampl
ha
gene
sequenc
influenza
partial
caus
sampl
bia
popul
genet
standpoint
larg
proport
mutat
occur
extern
branch
infect
host
rapidli
increas
therefor
one
conclud
mutat
rate
low
rel
small
number
mutat
intern
branch
analysi
even
conserv
estim
mutat
rate
indic
sarscov
popul
alreadi
harbor
consider
amount
genet
divers
emerg
time
sarscov
special
import
dissect
origin
viru
well
dynam
epidem
time
recent
common
ancestor
isol
estim
februari
novemb
although
consist
date
earliest
known
case
sar
estim
studi
also
suggest
sarscov
could
present
longer
gener
believ
around
novemb
one
possibl
scenario
sarscov
alreadi
infect
peopl
spring
fail
caus
epidem
spread
howev
suppress
summer
similar
summer
reemerg
around
novemb
caus
epidem
given
current
reemerg
sar
case
scenario
becom
like
inde
media
report
sarslik
symptom
patient
spring
although
none
convincingli
confirm
altern
scenario
common
ancestor
sarscov
live
spring
host
anim
recent
find
high
sequenc
homolog
isol
newli
emerg
sar
case
decemb
isol
mask
palm
civet
make
civet
primari
suspect
reservoir
sarscov
estim
mutat
rate
synonym
nonsynonym
substitut
rate
sarscov
genom
moder
compar
coronaviru
rna
virus
suggest
sarscov
unusu
coronaviru
term
speed
nucleotid
amino
acid
chang
base
mutat
rate
estim
studi
emerg
time
recent
common
ancestor
isol
place
februari
novemb
suggest
sarscov
could
human
earli
spring
without
caus
sever
epidem
obtain
complet
genom
sequenc
ncbi
websit
among
five
sequenc
obtain
host
collect
mainland
china
remain
sequenc
urbani
five
singaporean
sequenc
host
geograph
region
detail
inform
sequenc
shown
tabl
clustal
x
windowbas
user
interfac
clustal
w
use
align
multipl
sequenc
align
manual
examin
adjust
gene
annot
inform
nucleotid
posit
design
studi
refer
sequenc
genbank
access
id
avoid
complic
singl
nucleotid
variat
analyz
align
gap
exclud
led
identif
total
singl
nucleotid
variat
among
sequenc
averag
nucleotid
differ
two
sequenc
comput
program
use
calcul
pairwis
nucleotid
differ
result
genet
distanc
correct
juke
cantor
method
phylogeni
sampl
reconstruct
use
neighborjoin
maximum
parsimoni
method
mutat
rate
estim
principl
number
nucleotid
differ
two
sequenc
divid
twice
diverg
time
ie
time
recent
common
ancestor
due
better
document
contact
histori
mutat
rate
estim
sequenc
whose
host
mainland
china
sequenc
urbani
five
singaporean
sequenc
first
rang
diverg
time
pair
sequenc
infer
base
inform
infect
histori
report
strain
isol
date
sequenc
releas
date
addit
file
exampl
diverg
time
isol
urbani
estim
rang
day
second
nucleotid
differ
pair
sequenc
calcul
adjust
reduc
effect
sequenc
error
potenti
mutat
cell
cultur
three
strategi
use
first
strategi
use
reduc
number
pairwis
nucleotid
differ
averag
number
nucleotid
differ
observ
five
close
relat
singaporean
sequenc
strategi
effect
assum
real
nucleotid
differ
among
five
sequenc
observ
differ
reflect
level
error
second
strategi
use
reduc
pairwis
nucleotid
differ
two
add
day
diverg
time
account
cell
cultur
time
strategi
assum
mutat
rate
cell
cultur
human
host
averag
sequenc
error
one
nucleotid
per
genom
third
strategi
exclud
nucleotid
variant
observ
singleton
among
human
sarscov
sequenc
report
ration
nonsingleton
mutat
observ
sampl
much
less
like
due
sequenc
error
well
mutat
laboratori
passag
viru
strategi
appar
conserv
regard
lower
bound
mutat
rate
final
mutat
rate
per
site
per
year
estim
dij
genet
distanc
sequenc
j
tij
twice
diverg
time
number
day
n
number
sequenc
mutat
codon
nonsynonym
nonsil
chang
amino
acid
synonym
silent
otherwis
number
nonsynonym
mutat
per
nonsynonym
site
ka
number
synonym
mutat
per
synonym
site
ks
comput
use
method
li
wu
luo
nonsynonym
synonym
substitut
rate
calcul
use
diverg
time
estim
second
strategi
appli
rate
estim
number
nucleotid
differ
use
adjust
first
strategi
separ
nonsynonym
synonym
mutat
zz
carri
data
collect
sequenc
align
particip
data
analysi
wrote
manuscript
hl
compar
mutat
rate
among
rna
virus
xw
collect
estim
date
isol
yz
particip
data
analysi
kz
ypz
eb
particip
design
coordin
studi
yxf
conceiv
studi
particip
design
coordin
write
author
read
approv
final
manuscript
